Glucagon-Like Peptide (GLP)-1(9-36)Amide-Mediated Cytoprotection Is Blocked by Exendin(9-39) Yet Does Not Require the Known GLP-1 ReceptorBAN, Kiwon; KIM, Kyoung-Han; CHO, Chan-Kyung et al.Endocrinology (Philadelphia). 2010, Vol 151, Num 4, pp 1520-1531, issn 0013-7227, 12 p.Article

CENTRAL GLP-1 ACTIONS ON ENERGY METABOLISMVELASQUEZ, Douglas A; BEIROA, Daniel; VAZQUEZ, María J et al.Vitamins and hormones. 2010, Vol 84, pp 303-317, issn 0083-6729, 15 p.Article

Agonistes du GLP-1: Les pistes pour un choix éclairé : EASD 2012: La SéléctionMOSNIER-PUDAR, Helen.Diabète & obésité. 2012, Vol 7, Num 63, pp 307-308, issn 1957-5238, 2 p.Article

Minireview: Update on Incretin Biology: Focus on Glucagon-Like Peptide-1BRUBAKER, Patricia L.Endocrinology (Philadelphia). 2010, Vol 151, Num 5, pp 1984-1989, issn 0013-7227, 6 p.Article

Characterization of an N-acylated glucagon-like peptide-1 derivative by electron capture dissociationHASELMANN, Kim F; NIELSEN, Per F; ZUBAREV, Roman A et al.Journal of the American Society for Mass Spectrometry. 2005, Vol 16, Num 4, pp 548-552, issn 1044-0305, 5 p.Article

A role for GLP-1(7-36)NH₂ in the central control of feeding behaviourLAMBERT, P. D; WILDING, J. P. H; GHATEI, M. A et al.Digestion. 1993, Vol 54, Num 6, pp 360-361, issn 0012-2823Conference Paper

Investigation of the processing of GLP-1(7-36)amide by membrane peptidasesMCGREGOR, G. P; HUPE-SODMANN, K; BRIDENBAUGH, R et al.Digestion. 1993, Vol 54, Num 6, issn 0012-2823, p. 373Conference Paper

Evidence that Intestinal Glucagon-Like Peptide-1 Plays a Physiological Role in SatietyWILLIAMS, Diana L; BASKIN, Denis G; SCHWARTZ, Michael W et al.Endocrinology (Philadelphia). 2009, Vol 150, Num 4, pp 1680-1687, issn 0013-7227, 8 p.Article

Sulfonylurea compounds uncouple the glucose dependence of the insulinotropic effect of glucagon-like peptide 1DE HEER, Jocelyn; HOIST, Jens J.Diabetes (New York, NY). 2007, Vol 56, Num 2, pp 438-443, issn 0012-1797, 6 p.Article

The effect of exenatide re-exposure on safety and efficacyFALUDI, Peter; BRODOWS, Robert; BURGER, Jude et al.Peptides (New York, NY. 1980). 2009, Vol 30, Num 9, pp 1771-1774, issn 0196-9781, 4 p.Article

Glucagon-like peptide 1 secretion by the L-cell : The view from withinLIM, Gareth E; BRUBAKER, Patricia L.Diabetes (New York, NY). 2006, Vol 55, issn 0012-1797, S70-S77, SUP2Conference Paper

Assessment of phage display as a method to generate GLP-1 analogsGARRARD, L; RUIS, N; TAM, C et al.Digestion. 1993, Vol 54, Num 6, pp 393-394, issn 0012-2823Conference Paper

Analogues du GLP-1CHARPENTIER, Guillaume; LE PAPE, Gilles.La Revue du praticien. Médecine générale. 2011, Num 859, pp 280-281, issn 0989-2737, 2 p.Article

Insulin Regulates Glucagon-Like Peptide-1 Secretion from the Enteroendocrine L CellLIM, Gareth E; HUANG, Guan J; FLORA, Nina et al.Endocrinology (Philadelphia). 2009, Vol 150, Num 2, pp 580-591, issn 0013-7227, 12 p.Article

Lys⁹ for Glu⁹ substitution in glucagon-like peptide-1(7-36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9-36)amide and exendin (9-39)GREEN, B. D; MOONEY, M. H; GAULT, V. A et al.Metabolism, clinical and experimental. 2004, Vol 53, Num 2, pp 252-259, issn 0026-0495, 8 p.Article

Glucagon-like peptide-1 and energy homeostasisBURCELIN, Rémy; CANI, Patrice D; KNAUF, Claude et al.The Journal of nutrition. 2007, Vol 137, Num 11, issn 0022-3166, 2534S-2538S, SUPConference Paper

Effects of glucagon-like peptide-1 (7-36) amide on neurohypophysial hormone secretion induced by acute hyperosmotic challengeBOJANOWSKA, E; STEMPNIAK, B.Neuropeptides (Edinburgh). 2003, Vol 37, Num 1, pp 45-50, issn 0143-4179, 6 p.Article

Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cellsLEE, Young-Sun; JUN, Hee-Sook.Metabolism, clinical and experimental. 2014, Vol 63, Num 1, pp 9-19, issn 0026-0495, 11 p.Article

Glucagon-Like Peptide 1 Recruits Microvasculature and Increases Glucose Use in Muscle via a Nitric Oxide-Dependent MechanismWEIDONG CHAI; ZHENHUA DONG; NASUI WANG et al.Diabetes (New York, NY). 2012, Vol 61, Num 4, pp 888-896, issn 0012-1797, 9 p.Article

Monosodium glutamate stimulates secretion of glucagon-like peptide-1 and reduces postprandial glucose after a lipid-containing mealHOSAKA, H; KUSANO, M; ZAI, H et al.Alimentary pharmacology & therapeutics. 2012, Vol 36, Num 9, pp 895-903, issn 0269-2813, 9 p.Article

Mechanisms Underlying Metformin-Induced Secretion of Glucagon-Like Peptide-1 from the Intestinal L CellMULHERIN, Andrew J; OH, Amy H; KIM, Helena et al.Endocrinology (Philadelphia). 2011, Vol 152, Num 12, pp 4610-4619, issn 0013-7227, 10 p.Article

Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesisTOMAS, Eva; HABENER, Joel F.Trends in endocrinology and metabolism. 2010, Vol 21, Num 2, pp 59-67, issn 1043-2760, 9 p.Article

Le liraglutideGERSON, Michel.Médecine (Montrouge). 2010, Vol 6, Num 7, pp 302-305, issn 1777-2044, 4 p.Article

Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal systemOSAKA, Toshimasa; ENDO, Mari; YAMAKAWA, Midori et al.Peptides (New York, NY. 1980). 2005, Vol 26, Num 9, pp 1623-1631, issn 0196-9781, 9 p.Article

β-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1YAZHOU LI; XIEMIN CAO; LI, Li-Xin et al.Diabetes (New York, NY). 2005, Vol 54, Num 2, pp 482-491, issn 0012-1797, 10 p.Article